Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Adjuvant treatment by in vivo activation of dendritic cells

Adjuvant treatment by in vivo activation of dendritic cells

US Patent 6423539 · Granted Jul 23, 2002

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative disea2025
Disease-associated antigens and methods of use thereof2024
Methods of identifying and treating patient populations amenable to cancer immun2023
Antibody adjuvant conjugates2023
Methods for cancer treatment2023
Immunoconjugates targeting HER22022
Methods of determining patient populations amenable to immunomodulatory treatmen2022
Antibody adjuvant conjugates2021
2-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative disea2021
Disease-associated antigens and methods of use thereof2021
Method for treating neurodegenerative diseases2021
2-arylbenzimidazoles as PPARGC1A activators for treating neurodegenerative disea2020